StockData
Vertex Pharmaceuticals Inc logo

Vertex Pharmaceuticals Inc

VRTXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 4, 2026Score 15/3037% above fair value
$553.15−5.73 (-1.03%)

Close on Nov 2, 2026Market cap $140.20BP/E 32.2Yield –

Vertex Pharmaceuticals Deferred tax provision (benefit) — Federal by Year

Deferred tax provision (benefit) — Federal ($M) ($M)

Vertex Pharmaceuticals Deferred tax provision (benefit) — Federal: -$527M in FY2025, up 20.1% from a year earlier.

Latest, FY2025
-527
Period ended Dec 31, 2025
Change on a year earlier
+20.1%
-439 in FY2024
History
11 years
Since FY2015
Sources
9
Documents cited below

Where the FY2025 figure comes from

Source: Form 10-K (filed 2026-02-13) ↗

Reported in Form 10-K Note (Income Taxes).

Annual history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedDeferred tax provision (benefit) — Federal ($M) ($M)Year on yearSource
FY2025Dec 31, 2025-527+20.1%Form 10-K (filed 2026-02-13) ↗
FY2024Dec 31, 2024-439-23.0%Form 10-K (filed 2026-02-13) ↗
FY2023Dec 31, 2023-570+41.1%Form 10-K (filed 2026-02-13) ↗
FY2022Dec 31, 2022-404+994.9%Form 10-K (filed 2025-02-13) ↗
FY2021Dec 31, 2021-36.9-107.2%Form 10-K (filed 2024-02-15) ↗
FY2020Dec 31, 2020510+176.8%Form 10-K (filed 2023-02-10) ↗
FY2019Dec 31, 2019184-116.7%Form 10-K (filed 2022-02-09) ↗
FY2018Dec 31, 2018-1,105+871.0%Form 10-K (filed 2021-02-11) ↗
FY2017Dec 31, 2017-114-708.6%Form 10-K (filed 2020-02-13) ↗
FY2016Dec 31, 201618.7+3,640.0%Form 10-K (filed 2019-02-13) ↗
FY2015Dec 31, 20150.50–Form 10-K (filed 2018-02-15) ↗

Cite this data

StockData. (2026). Vertex Pharmaceuticals Deferred tax provision (benefit) — Federal ($M), annual FY2015–FY2025 [Data set]. Compiled from Vertex Pharmaceuticals SEC filings and investor materials. https://stockdatahq.com/stocks/vrtx/kpis/tax-def-fed

See every metric in the Vertex Pharmaceuticals KPI table. Data updated Nov 2, 2026.